[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 2014

Hidradenitis SuppurativaCurrent Progress and Future Questions

Author Affiliations
  • 1Department of Dermatology, Massachusetts General Hospital, Boston
  • 2Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 3Department of Dermatology, Harvard Medical School, Boston, Massachusetts
JAMA Dermatol. 2014;150(12):1263-1264. doi:10.1001/jamadermatol.2014.1871

Hidradenitis suppurativa (HS) is a chronic, destructive, debilitating inflammatory skin disease characterized by recurrent, painful, deep-seated nodules and/or abscesses in intertriginous areas.1 It is also relatively common, with a reported prevalence as high as 1% to 4%.2,3 Nevertheless, HS has historically been an orphan disease, unclaimed by any specialty, owing, perhaps largely, to the treatment challenges it poses for physicians and the resulting nonadherence on the part of patients.

First Page Preview View Large
First page PDF preview
First page PDF preview